This article is more than 5 years old. Information may no longer be current.

VIDEO: Surgeon discusses durability of effect of anti-VEGF therapy in DME patients

Issue: January 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

VIENNA — At the Advanced Retinal Therapy meeting, Jennifer K. Sun, MD, speaks about the durability of effect of anti-VEGF therapy in diabetic eye disease. Although long-term results are needed, shorter term results from DRCR.net protocol studies suggest a sustained influence of anti-VEGF therapy on diabetic eye disease and visual acuity, and perhaps a reduced need for injections.